Garnuszek, P.; Karczmarczyk, U.; Maurin, M.; Sikora, A.; Zaborniak, J.; Pijarowska-Kruszyna, J.; Jaroń, A.; Wyczółkowska, M.; Wojdowska, W.; Pawlak, D.;
et al. PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties. Int. J. Mol. Sci. 2021, 22, 2731.
https://doi.org/10.3390/ijms22052731
AMA Style
Garnuszek P, Karczmarczyk U, Maurin M, Sikora A, Zaborniak J, Pijarowska-Kruszyna J, Jaroń A, Wyczółkowska M, Wojdowska W, Pawlak D,
et al. PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties. International Journal of Molecular Sciences. 2021; 22(5):2731.
https://doi.org/10.3390/ijms22052731
Chicago/Turabian Style
Garnuszek, Piotr, Urszula Karczmarczyk, Michał Maurin, Arkadiusz Sikora, Jolanta Zaborniak, Justyna Pijarowska-Kruszyna, Antoni Jaroń, Monika Wyczółkowska, Wioletta Wojdowska, Dariusz Pawlak,
and et al. 2021. "PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties" International Journal of Molecular Sciences 22, no. 5: 2731.
https://doi.org/10.3390/ijms22052731
APA Style
Garnuszek, P., Karczmarczyk, U., Maurin, M., Sikora, A., Zaborniak, J., Pijarowska-Kruszyna, J., Jaroń, A., Wyczółkowska, M., Wojdowska, W., Pawlak, D., Lipiński, P. F. J., & Mikołajczak, R.
(2021). PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties. International Journal of Molecular Sciences, 22(5), 2731.
https://doi.org/10.3390/ijms22052731